Exclusive: Capricor CEO Talks Exondys Competition By: Benzinga via Benzinga May 03, 2017 at 07:53 AM EDT Even as it recovered from poor fourth-quarter results, Capricor Therapeutics Inc (NASDAQ: CAPR) pumped a little hope into the world of ... Read More >> Related Stocks: Capricor Therap Johnson & Johnson Sarepta Therapeutics